BioAtla, Inc. (BCAB)
$1.55-2.52%Close
SELLCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 0.76
- P/E (TTM)
- -0.07
- Short % float
- 7.06%
- Days to cover
- 1.4
- SI change
- -19.7%
- 1W
- +23.02%
- 1M
- +26.02%
- vs SPY 1W
- +21.86%
- vs SPY 1M
- +23.02%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on BCAB?
- LOPJLB’s latest quantitative signal on BioAtla, Inc. (BCAB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BCAB in?
- BioAtla, Inc. (BCAB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BioAtla, Inc. (BCAB) do?
- BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cancers. The company's primary experimental therapeutic, BA3011, is a conditionally active biologic antibody-drug conjugate (CAB ADC) being investigated for its potential against soft tissue and bone sa…